Publications

- Lereclus E, Tout M, Girault A, Baroukh N, Caulet M, Borg C, Bouché O, Ternant D, Paintaud G, Lecomte T, Raoul W. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen. BMC Cancer (2017). Mar 27;(1): 220.

- Dalloneau E, N. Baroukh, K. Mavridis, A. Maillet, F. Gueugnon, Y. Courty, A. Petit, M. Del Rio, S. Serge Guyetant, C. Dhommée, C. Arnoult, C. Passot, A. Scorilas, V. Gouilleux-Gruart, and N. Heuzé-Vourc'h. Downregulation of FcRn expression in non-small-cell lung cancer tissue is associated with a poor prognosis. Oncotarget. (2016) Jun 15;Vol 7, No 34: 54415-29.

- Ternant D, Arnoult C, Pugnière M, Dhommée C, Drocourt D, Perouzel E, Passot C, Baroukh N, Mulleman D, Tiraby G, Watier H, Paintaud G, Gouilleux-Gruart V. «IgG1 allotypes influence the pharmacokinetics of therapeutic monoclonal antibodies through FcRn binding ». J Immunol. (2016) Dec 18; 196 :607-613.

- Passot C, Azzopardi N, Renault S, Baroukh N, Arnoult C, Ohresser M, Boisdron-Celle M, Gamelin E, Watier H, Paintaud G, Gouilleux-Gruart V. « Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies". MAbs. (2013) Jul 1; 5(4):614-9.

- Baroukh N. and Van Obberghen E. "Function of microRNA-375 and microRNA-124a in pancreas and brain". Febs J. (2009) Revue. 276(22): 6509-6521.

- El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D & Van Obberghen E. "MiR-375 targets 3'- phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells". Diabetes (2008) 57(10): 2708-2717.

- Baroukh, N., Ravier M., Loder M.K., Hill E.V., Bounacer, A., Scharfmann, R., Rutter G.A., and Van Obberghen E. "MicroRNA-124a2 regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines". J Biol Chem (2007) 282(27):19575-88.

- Grosskopf, I., N. Baroukh, Lee S. J., Kamari Y, Harats D, Rubin EM, Pennacchio LA and AD Cooper "Apolipoprotein AV deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants." Arterioscler. Thromb. Vasc. Biol. (2005) 25 (12):2573-9.

- Baroukh, N., N. Nadav, J. Chang M. Shoukry, V. Afzal, E.M. Rubin, L.A. Pennacchio. "Comparative Genomic Analysis Reveals a Distant Liver Enhancer Upstream of the COUP-TFII Gene". Mamm Genome. (2005); 16(2):91-5. 

- Biro, J.C., N. Baroukh. "Repeats: Sequence Alike. Prediction of Genome-Wide Associative Regulatory Role of Short and Long Interspersed Nucleotide Elements (SINE and LINE)". Med Hypotheses. (2005); Vol 1, No 1.

- Baroukh, N., D. Recalde, C. Viglietta, S. Prince, J. Verona, L. Vergnes, J Pidoux, M Nazeem Nanjee, F Brites, A. Ochoa, G. Castro, M. M. Zakin, N. E. Miller, L.M. Houdebine. "Human apoAI/CIII/AIV gene cluster transgenic rabbits: effects of a high-cholesterol diet". Febs Lett. (2004); 572: 294-298. 

- Baroukh, N., E. Bauge, J. Akiyama, J. Chang, V. Afzal, J-C Fruchart, E.M. Rubin, J. Fruchart-Najib, L.A Pennacchio. «Analysis of apolipoprotein AV, CIII and plasma triglyceride concentrations in genetically engineered mice». Arterioscler. Thromb. Vasc. Biol. (2004); 24(7): 1297-1302.

- Baroukh, N., C. Lopez, L Vergnes, M.C. Saleh, D. Recalde, L. Vergnes, M.A. Ostos, L. Fiette, J.C. Fruchart, G. Castro, M.M. Zakin and A. Ochoa. "Expression and Secretion of Human Apolipoprotein A-I in the Heart". Febs Lett. (2004); 557 (1-3): 39-44.

- Pennacchio L. A., N. Baroukh, E.M. Rubin. "Human-Mouse Comparative Genomics: Successes and Failures to reveal Functional Regions of the Human Genome". Cold Spring Harbor Symposia Quantitative Biology. (2003); 68:303-9.

- Saleh M.C., Espinosa de los Monteros A., de Arriba Zerpa G.A., Fontaine I., Djordjijevic D., Baroukh N., Ortiz E., Lewis S., Fiette L., Arosio P., Belzung C., Connor J.R., de Vellis J., Pasquini J.M., Zakin M.M., Baron B., and Guillou F. "Myelination and motor coordination are increased in transferrin transgenic mice". J. Neur. Res. (2003); 72(5): 587-594.

- Ostos MA., D. Recalde, N. Baroukh, A. Callego, M. Rouis, G. Castro, MM. Zakin. "Fructose Intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV- transgenic mice". J Nutr (2002); 132(5): 918-23.

- Baroukh N, M. A. Ostos, L. Vergnes, D. Recalde, B. Staels, J-C. Fruchart, A. Ochoa, G. Castro and M. M. Zakin. "Expression of Human Apolipoprotein A-I/C-III/A-IV Gene Cluster in Mice Reduces Atherogenesis in Response to a High Fat-High Cholesterol Diet". FEBS Lett. (2001); 502: 16-20.

- Ostos, MA., M.A. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J.M. Caillaud, A.Ochoa, M.M. Zakin. "Antioxidative and antiatherosclerotic effects of human apoA-IV in apoE-deficient mice". Arterioscler. Thromb. Vasc. Biol. (2001); 21: 1023-1028.

- Baroukh, N., L. Vergnes, M. Ostos, G. Castro, N. Duverger, M.N. Nanjee, D. Najib, J.C. Fruchart, N.E. Miller, M.M. Zakin and A. Ochoa. "Expression of the human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis". Arterioscler. Thromb. Vasc. Biol. (2000); 20 :2267-2274.

- Vergnes, L., N. Baroukh, T. Léhy, L. Moizo, A. Bado, M. Baralle, F.E. Baralle, M.M. Zakin and A Ochoa. "Human apolipoprotein A-IV reduces gastric secretion and diminishes ulcer formation in transgenic mice". FEBS Lett. (1999); 460 : 178-181.

- Baroukh, N., L. Vergnes, M. A. Ostos, M. Zakin, A. Ochoa. "Les animaux génétiquement modifiés : Etude du transport des lipides et de l'athérosclérose ». Annales de l'Institut Pasteur/Actualité (1999); 10 : 63-88.